Stifel Downgrades InterMune; Roche Offer 'Appropriate Ending'
August 25, 2014 at 11:34 AM EDT
Shares of InterMune (NASDAQ: ITMN) were downgraded to Hold from Buy by Stifel following Roche's proposed $8.3 billion acquisition ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.